Preliminary study on reducing oral moist snuff use

被引:9
作者
Hatsukami, DK
Edmonds, A
Schulte, S
Jensen, J
Le, CT
Losey, L
Carmella, SG
Hecht, SS
机构
[1] Univ Minnesota, Tobacco Use Res Ctr, Minneapolis, MN 55414 USA
[2] Univ Minnesota, Ctr Canc, Minneapolis, MN 55455 USA
关键词
snuff tobacco; tobacco exposure reduction; carcinogens;
D O I
10.1016/S0376-8716(03)00006-1
中图分类号
R194 [卫生标准、卫生检查、医药管理];
学科分类号
摘要
Background: Tobacco exposure reduction may be an alternative treatment approach for those tobacco users who are unwilling or unable to quit tobacco use. However, very little information is available on the feasibility of this type of intervention, especially in the area of oral moist snuff tobacco (ST). This pilot study examined whether reducing ST use using various methods can be achieved and whether this reduction results in lower exposure to carcinogens. Methods: Moist snuff users (N = 40 males) were randomly assigned to 4 mg nicotine gum, non-tobacco mint snuff, brand switching, or elimination of ST use in specific situations. These approaches were used to reduce ST use or nicotine exposure by at least 25% for the first 2 weeks and 50% the subsequent 6 weeks of treatment. Follow-up sessions occurred at 12 and 26 weeks. Results: Significant reductions were observed in tins per week and cotinine levels across all conditions. Among the intent-to-treat population, the abstinence rate was 15% at 26 weeks. Reduction in nicotine exposure was associated with reduction in exposure to nitrosamines. Conclusion: Reduction in ST use may be a viable approach for those oral moist ST users with no immediate quit plans. Future research in this area is needed. (C) 2003 Elsevier Science Ireland Ltd. All rights reserved.
引用
收藏
页码:215 / 220
页数:6
相关论文
共 15 条
[1]  
BOLINDER G, 1997, LONG TERM USE SMOKEL
[2]  
BURNS D, 1997, SOC RES NIC TOB 3 AN
[3]  
Djordjevic M. V., 1995, TOB CONTROL, V4, P62, DOI DOI 10.1136/TC.4.1.62
[4]   Effects of behavioral and pharmacological treatment on smokeless tobacco users [J].
Hatsukami, D ;
Jensen, J ;
Allen, S ;
Grillo, M ;
Bliss, R .
JOURNAL OF CONSULTING AND CLINICAL PSYCHOLOGY, 1996, 64 (01) :153-161
[5]  
Hatsukami D K, 1999, Nicotine Tob Res, V1, P21, DOI 10.1080/14622299050011131
[6]   Treatment of spit tobacco users with transdermal nicotine system and mint snuff [J].
Hatsukami, DK ;
Grillo, M ;
Boyle, R ;
Allen, S ;
Jensen, J ;
Bliss, R ;
Brown, S .
JOURNAL OF CONSULTING AND CLINICAL PSYCHOLOGY, 2000, 68 (02) :241-249
[7]  
HATSUKAMI DK, IN PRESS PHARM BIOCH
[8]   Biochemistry, biology, and carcinogenicity of tobacco-specific N-nitrosamines [J].
Hecht, SS .
CHEMICAL RESEARCH IN TOXICOLOGY, 1998, 11 (06) :559-603
[9]  
HECHT SS, 1986, CANCER RES, V46, P4162
[10]   Tobacco smoke carcinogens and lung cancer [J].
Hecht, SS .
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 1999, 91 (14) :1194-1210